M&A

Houston logistics SaaS company makes strategic acquisition

Houston-based Velostics has made an M&A move to integrate new software onto its platform. Photo by Tom Fisk from Pexels

A Houston company that has created software to automate logistics at terminals, plants, and warehouses has announced the acquisition of a California-based startup.

Houston-based Velostics Inc. has acquired Terusama, a logistics tech company with dock management and truck scheduling capabilities. The company's software solution that speeds up truck loading and unloading w2ill be rolled into Velostics's platform.

"We are enthusiastic about integrating Terusama's truck scheduling with Velostics' load automation and check-in solutions. The combined offering enables Velostics to create a new standard for inbound logistics automation," says Gaurav Khandelwal, CEO of Velostics, in a news release.

"We can now bring to market unmatched ROI on logistics automation, by providing visibility into future demand, reducing delays associated with load prep and staging, eliminating manual errors, improving throughput and reducing operating costs and detention at our customers' facilities," he continues.

The two software-as-a-service solutions aim to reduce delays and errors, improve ROI, and provide visibility into deliveries and future product demand.

"Appointment scheduling technology is a powerful lever to track, measure, and improve operations at facilities large and small. Being part of the Velostics family gives Terusama the opportunity to not only continue that mission, but also to accelerate and to serve larger markets," says Andrew Denta, CEO of Terusama. "I have full confidence that Velostics' unique capabilities, out-of-the-box integrations with carriers and solid support resources will further fuel the growth at Terusama and further reduce cost to the customer."

The details of the deal were not disclosed. Founded in San Francisco last year, Terusama has raised $150,000 from Y Combinator, according to Crunchbase, and has two employees.

Terusama's trucking software will be implemented into Velostics's services. Image via terusama.com

Trending News

Building Houston

 
 

Houston-based medical device and biotech startup Steradian Technologies has been recognized by the Bill and Melinda Gates Foundation. Photo by Dwight C. Andrews/Greater Houston Convention and Visitors Bureau

A female-founded biotech startup has announced that it has received a grant from the Bill & Melinda Gates Foundation.

Steradian Technologies has developed a breath-based collection device that can be used with diagnostic testing systems. Called RUMI, the device is non-invasive and fully portable and, according to a news release, costs the price of a latte.

“We are extremely honored to receive this award and be recognized by the Bill & Melinda Gates Foundation, a leader in global health. This funding will propel our work in creating deep-tech diagnostics and products to close the equity gap in global public health," says Asma Mirza, CEO and co-founder of Steradian Technologies, in the release. “The RUMI will demonstrate that advanced technology can be delivered to all areas of the world, ensuring the Global South and economically exploited regions receive access to high-fidelity diagnostics instead of solutions that are ill-suited to the environment.”

RUMI uses novel photon-based detection to collect and diagnose infectious diseases in breath within 30-seconds, per the release, and will be the first human bio-aerosol specimen collector to convert breath into a fully sterile liquid sample and can be used for many applications in direct disease detection.

"As the healthcare industry continues to pursue less invasive diagnostics, we are very excited that the foundation has identified our approach to breath-based sample collection as a standout worthy of their support," says John Marino, chief of product development and co-founder. “We look forward to working with them to achieve our goals of better, faster, and safer diagnostics."

Founded in 2017, Steradian Technologies is funded and supported by XPRIZE, Johnson & Johnson’s Lung Cancer Initiative, JLABS TMCi, Capital Factory, Duke Institute of Global Health, and Johnson & Johnson’s Center for Device Innovation.

The amount granted by the Bill & Melinda Gates Foundation was not disclosed. The Seattle-based foundation is led by CEO Mark Suzman and co-chaired by Bill Gates and Melinda French Gatess.

Trending News